Bloomberg Law
Free Newsletter Sign Up
Bloomberg Law
Welcome
Go
Free Newsletter Sign Up

Aetna, Bayer Kickback Whistleblower Suit Dismissal Affirmed

Jan. 21, 2022, 9:25 PM

The U.S. Justice Department properly sought dismissal of a whistleblower’s False Claims Act suit alleging a kickback scheme against drugmakers and pharmacy benefit managers including Bayer Healthcare Pharmaceuticals Inc., Biogen Inc., Aetna Inc., and Cigna Corp., the First Circuit affirmed Friday.

A district court didn’t err in backing the DOJ’s determination that John R. Borzilleri’s suit accusing the companies of engaging in a fraudulent scheme to overcharge multiple sclerosis drugs under Medicare Part D would be too burdensome on government resources if allowed to continue, the U.S. Court of Appeals for the First Circuit ruled.

In ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.